A predictive model to estimate fever after receipt of the second dose of Pfizer‐BioNTech coronavirus disease 2019 vaccine: An observational cohort study-Reference-Cited by-同舟云学术

A predictive model to estimate fever after receipt of the second dose of Pfizer‐BioNTech coronavirus disease 2019 vaccine: An observational cohort study

Published:2022-07 Issue:4 Volume:5 Page:
ISSN:2398-8835
Container-title:Health Science Reports
language:en
Short-container-title:Health Science Reports

Author:

Chiba Satoru¹^ORCID,Shinohara Kaoru²

Affiliation:

1. Department of Internal Medicine, Sapporo Suzuki Hospital Medical Corporation Kenseikai Hokkaido Japan

2. Department of Psychiatric Medicine, Sapporo Suzuki Hospital Medical Corporation Kenseikai Hokkaido Japan

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hsr2.742

Reference28 articles.

1. WHO.Director‐General's Opening Remarks at the Media Briefing on COVID‐19‐11 March;2020.https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020

2. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up

3. Clinical Efficacy and Safety of Antiviral Drugs in the Extended Use against COVID-19: What We Know So Far

4. Effect of early oseltamivir on outpatients without hypoxia with suspected COVID-19

5. ChibaS.Smoking is associated with constant cough which is resistant to oseltamivir therapy for suspected COVID‐19.Res. Sq.2021.doi:10.21203/rs.3.rs-287518/v2

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persistent cough in mild COVID‐19 successfully treated with chikujountanto, a traditional Kampo medicine: An observational cohort study;Traditional & Kampo Medicine;2024-09-11

2. Keigai-rengyo-to as post-exposure prophylaxis for severe acute respiratory syndrome coronavirus 2 infection;Respiratory Investigation;2023-11

3. Trajectory analyses to identify persistently low responders to COVID-19 vaccination in patients with inflammatory bowel disease: a prospective multicentre controlled study, J-COMBAT;Journal of Gastroenterology;2023-08-10